NCT04653077

MSCs Therapy for Cerebral Palsy

Bone Marrow Stem Cells Transplantation for the Treatment of Cerebral Palsy

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Aljazeera Hospital · Academic / Other
• Sex: All
• Age: 2 Years – 12 Years
• Healthy volunteers: Not accepted

Summary

Cerebral palsy (CP) is the most common physical disability in childhood. CP comprises a heterogeneous group of disorders that are the result of a non-progressive disruption or injury that occurred during fetal brain development or within the first two years of life.

Detailed description

This disruption can result in spasticity, dystonia, muscle contractures, weakness and difficulty in coordination that ultimately affects the ability to control movements. Resultant activity limitations may affect gross motor movements, fine motor movements, speech and communication, as well as eating and drinking.

Conditions

• Stem Cell Transplant Complications

Interventions

Type	Name	Description
OTHER	stem cells	Intravenous and Intrathecal transplantation of specific populations of purified bone marrow-derived stem cells and mesenchymal stem cells.

Timeline

• Start date: 2020-12-02
• Primary completion: 2022-10-15
• Completion: 2022-12-01
• First posted: 2020-12-04
• Last updated: 2020-12-04

Locations

1 site across 1 country: Egypt